ArticlebioRxiv : the preprint server for biology2024
Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer.
Esther P B Rodman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.